Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115504904A reveals a safer route to 3-cyano-4-methoxy-2(1H)-pyridone using alpha-cyanoacetamide, eliminating toxic DMF-DMA and reducing costs.
Patent CN101143836A details a high-purity synthesis route using sodium pyrosulfite. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel enzyme process for chiral amine intermediate. High purity, mild conditions, scalable for pharma manufacturing.
Patent CN113135955B discloses a scalable route for C2 symmetric Trost ligands, offering cost reduction in asymmetric catalysis manufacturing and reliable supply.
Patent CN1301977C details a safer, high-yield route for 2-(N-methyl-N-methylsulfonylamino)pyrimidine, eliminating toxic cyanogen chloride for scalable pharmaceutical manufacturing.
Novel water-based method improves purity and yield. Reduces solvent costs and environmental impact for pharmaceutical intermediate manufacturing supply chains.
Patent CN106397239B reveals advanced amino acid ester ionic liquid synthesis offering high stereoselectivity and scalable green manufacturing solutions.
Novel supramolecular assembly inhibitor synthesis via click chemistry offering high purity and scalable production for pharmaceutical applications.
Novel Pd/Cu catalyzed C-H acetoxylation method for aryl pyrimidines. High yield up to 88%, mild conditions, ideal for API and OLED intermediate manufacturing.
Patent CN116397244B reveals efficient electrochemical route for high-purity glycoside derivatives, offering cost reduction and scalable manufacturing solutions for global pharmaceutical intermediates.
Advanced purification patent CN121021353A enables high-purity ADC linker production with simplified crystallization processes for reliable pharmaceutical intermediate supply chains.
Novel 7-step total synthesis of estrone from tetralone offers high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Novel Henry reaction method ensures high purity and scalable production for pharmaceutical intermediates supply chain efficiency and cost optimization globally
Discover the novel Cytosine-based route for Palbociclib parent nucleus. Enhanced purity, reduced costs, and scalable manufacturing for global supply chains.
Patent CN107880111B reveals a novel Glu-21 side-chain anchoring method for Liraglutide, enhancing coupling efficiency and purity for scalable manufacturing.
Advanced synthetic route for Leonurine (Syringic acid delta-guanidinobutyl ester) offering high purity and scalable production for global pharmaceutical supply chains.
Novel three-step synthesis method for abiraterone acetate impurities ensures high purity and safety. Reliable supply chain solutions for pharmaceutical intermediates manufacturing with cost reduction.
Patent CN1388804A reveals N-acyl substituted NCAs for efficient peptide production. Reduces steps and costs for pharmaceutical and agrochemical manufacturing.
Patent CN115611961B enables safe chemical synthesis of cholic acid intermediates reducing viral risks and ensuring supply chain stability for global pharmaceutical manufacturers.
Patent CN102659638B reveals a cost-effective Leonurine synthesis route featuring high purity and scalable steps for reliable pharmaceutical intermediate supply chains.